vs
Side-by-side financial comparison of INSEEGO CORP. (INSG) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
INSEEGO CORP. is the larger business by last-quarter revenue ($48.4M vs $47.7M, roughly 1.0× IRONWOOD PHARMACEUTICALS INC). INSEEGO CORP. runs the higher net margin — 1.0% vs -4.8%, a 5.7% gap on every dollar of revenue. On growth, INSEEGO CORP. posted the faster year-over-year revenue change (0.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $11.6M). Over the past eight quarters, INSEEGO CORP.'s revenue compounded faster (13.6% CAGR vs -20.2%).
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
INSG vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $47.7M |
| Net Profit | $469.0K | $-2.3M |
| Gross Margin | 42.2% | — |
| Operating Margin | 2.7% | 14.3% |
| Net Margin | 1.0% | -4.8% |
| Revenue YoY | 0.6% | -47.3% |
| Net Profit YoY | 182.9% | -200.9% |
| EPS (diluted) | $-0.02 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $47.7M | ||
| Q3 25 | $45.9M | $122.1M | ||
| Q2 25 | $40.2M | $85.2M | ||
| Q1 25 | $31.7M | $41.1M | ||
| Q4 24 | $48.1M | $90.5M | ||
| Q3 24 | $54.0M | $91.6M | ||
| Q2 24 | $51.6M | $94.4M | ||
| Q1 24 | $37.5M | $74.9M |
| Q4 25 | $469.0K | $-2.3M | ||
| Q3 25 | $1.4M | $40.1M | ||
| Q2 25 | $507.0K | $23.6M | ||
| Q1 25 | $-1.6M | $-37.4M | ||
| Q4 24 | $-566.0K | $2.3M | ||
| Q3 24 | $9.0M | $3.6M | ||
| Q2 24 | $624.0K | $-860.0K | ||
| Q1 24 | $-4.5M | $-4.2M |
| Q4 25 | 42.2% | — | ||
| Q3 25 | 41.6% | — | ||
| Q2 25 | 41.1% | — | ||
| Q1 25 | 47.3% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 36.4% | — | ||
| Q1 24 | 35.3% | — |
| Q4 25 | 2.7% | 14.3% | ||
| Q3 25 | 4.7% | 61.8% | ||
| Q2 25 | 3.2% | 53.2% | ||
| Q1 25 | -1.3% | -70.7% | ||
| Q4 24 | 3.7% | 34.8% | ||
| Q3 24 | 1.9% | 28.0% | ||
| Q2 24 | 3.6% | 26.5% | ||
| Q1 24 | -7.9% | 14.7% |
| Q4 25 | 1.0% | -4.8% | ||
| Q3 25 | 3.1% | 32.8% | ||
| Q2 25 | 1.3% | 27.7% | ||
| Q1 25 | -5.0% | -90.9% | ||
| Q4 24 | -1.2% | 2.5% | ||
| Q3 24 | 16.6% | 4.0% | ||
| Q2 24 | 1.2% | -0.9% | ||
| Q1 24 | -11.9% | -5.6% |
| Q4 25 | $-0.02 | $0.01 | ||
| Q3 25 | $0.03 | $0.23 | ||
| Q2 25 | $-0.03 | $0.14 | ||
| Q1 25 | $-0.16 | $-0.23 | ||
| Q4 24 | $0.62 | $0.03 | ||
| Q3 24 | $-0.06 | $0.02 | ||
| Q2 24 | $-0.02 | $-0.01 | ||
| Q1 24 | $-0.44 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.9M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-4.0M | $-261.8M |
| Total Assets | $93.8M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.9M | $215.5M | ||
| Q3 25 | $14.6M | $140.4M | ||
| Q2 25 | $13.2M | $92.9M | ||
| Q1 25 | $35.1M | $108.5M | ||
| Q4 24 | $39.6M | $88.6M | ||
| Q3 24 | $12.0M | $88.2M | ||
| Q2 24 | $49.0M | $105.5M | ||
| Q1 24 | $12.3M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $-4.0M | $-261.8M | ||
| Q3 25 | $-7.7M | $-264.2M | ||
| Q2 25 | $-10.5M | $-308.2M | ||
| Q1 25 | $-13.0M | $-334.1M | ||
| Q4 24 | $-12.9M | $-301.3M | ||
| Q3 24 | $-85.1M | $-311.3M | ||
| Q2 24 | $-101.8M | $-321.7M | ||
| Q1 24 | $-105.6M | $-330.5M |
| Q4 25 | $93.8M | $396.9M | ||
| Q3 25 | $85.8M | $396.1M | ||
| Q2 25 | $83.1M | $342.9M | ||
| Q1 25 | $93.0M | $327.2M | ||
| Q4 24 | $100.0M | $350.9M | ||
| Q3 24 | $113.4M | $389.5M | ||
| Q2 24 | $149.6M | $395.6M | ||
| Q1 24 | $122.1M | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.0M | $74.6M |
| Free Cash FlowOCF − Capex | $11.6M | $74.6M |
| FCF MarginFCF / Revenue | 24.0% | 156.3% |
| Capex IntensityCapex / Revenue | 0.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 25.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.5M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.0M | $74.6M | ||
| Q3 25 | $3.2M | $47.6M | ||
| Q2 25 | $-4.5M | $-15.1M | ||
| Q1 25 | $-3.5M | $20.0M | ||
| Q4 24 | $-14.2M | $15.2M | ||
| Q3 24 | $14.8M | $9.9M | ||
| Q2 24 | $27.6M | $33.5M | ||
| Q1 24 | $5.2M | $45.0M |
| Q4 25 | $11.6M | $74.6M | ||
| Q3 25 | $3.1M | $47.6M | ||
| Q2 25 | $-4.7M | $-15.1M | ||
| Q1 25 | $-3.5M | $19.9M | ||
| Q4 24 | $-14.3M | — | ||
| Q3 24 | $14.8M | $9.9M | ||
| Q2 24 | $27.6M | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | 24.0% | 156.3% | ||
| Q3 25 | 6.7% | 39.0% | ||
| Q2 25 | -11.6% | -17.7% | ||
| Q1 25 | -11.0% | 48.4% | ||
| Q4 24 | -29.7% | — | ||
| Q3 24 | 27.4% | 10.8% | ||
| Q2 24 | 53.5% | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.5% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 0.1% |
| Q4 25 | 25.50× | — | ||
| Q3 25 | 2.22× | 1.19× | ||
| Q2 25 | -8.81× | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | 1.65× | 2.71× | ||
| Q2 24 | 44.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
